Detalles de la búsqueda
1.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Oncology (Williston Park)
; 37(4): 176-183, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104758
2.
Clinical best practices in optimal monitoring, early diagnosis, and effective management of antibody-drug conjugate-induced interstitial lung disease or pneumonitis: a multidisciplinary team approach in Singapore.
Expert Opin Drug Metab Toxicol
; 18(12): 805-815, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636012
3.
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.
Asia Pac J Clin Oncol
; 17(4): 388-395, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502085
4.
Chemoradiation-induced changes in systemic inflammatory markers and their prognostic significance in oesophageal squamous cell carcinoma.
Br J Radiol
; 94(1122): 20200314, 2021 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33861156
Resultados
1 -
4
de 4
1
Próxima >
>>